The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Automation in Biopharmaceutical-Global Market Insights and Sales Trends 2024
Synopsis
The biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing RandD investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
The global Automation in Biopharmaceutical market size is expected to reach US$ 1588 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Automation in Biopharmaceutical in various end use industries. The expanding demands from the Research and Development and Clinical, are propelling Automation in Biopharmaceutical market. Clinical Stage Automation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drug Discovery Stage Automation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Automation in Biopharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Automation in Biopharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Automation in Biopharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Automation in Biopharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Automation in Biopharmaceutical covered in this report include Danaher, GE, PerkinElmer, Tecan Trading, Thermo Fisher Scientific, Bruker, Peak Analysis and Automation, Waters and Capsugel, etc.
The global Automation in Biopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis and Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
Global Automation in Biopharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Automation in Biopharmaceutical market, Segment by Type:
Clinical Stage Automation
Drug Discovery Stage Automation
Global Automation in Biopharmaceutical market, by Application
Research and Development
Clinical
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Automation in Biopharmaceutical companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing RandD investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
The global Automation in Biopharmaceutical market size is expected to reach US$ 1588 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Automation in Biopharmaceutical in various end use industries. The expanding demands from the Research and Development and Clinical, are propelling Automation in Biopharmaceutical market. Clinical Stage Automation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drug Discovery Stage Automation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Automation in Biopharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Automation in Biopharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Automation in Biopharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Automation in Biopharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Automation in Biopharmaceutical covered in this report include Danaher, GE, PerkinElmer, Tecan Trading, Thermo Fisher Scientific, Bruker, Peak Analysis and Automation, Waters and Capsugel, etc.
The global Automation in Biopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis and Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
Global Automation in Biopharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Automation in Biopharmaceutical market, Segment by Type:
Clinical Stage Automation
Drug Discovery Stage Automation
Global Automation in Biopharmaceutical market, by Application
Research and Development
Clinical
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Automation in Biopharmaceutical companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Automation in Biopharmaceutical
1.1 Automation in Biopharmaceutical Market Overview
1.1.1 Automation in Biopharmaceutical Product Scope
1.1.2 Automation in Biopharmaceutical Market Status and Outlook
1.2 Global Automation in Biopharmaceutical Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Automation in Biopharmaceutical Market Size by Region (2018-2029)
1.4 Global Automation in Biopharmaceutical Historic Market Size by Region (2018-2023)
1.5 Global Automation in Biopharmaceutical Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Automation in Biopharmaceutical Market Size (2018-2029)
1.6.1 North America Automation in Biopharmaceutical Market Size (2018-2029)
1.6.2 Europe Automation in Biopharmaceutical Market Size (2018-2029)
1.6.3 Asia-Pacific Automation in Biopharmaceutical Market Size (2018-2029)
1.6.4 Latin America Automation in Biopharmaceutical Market Size (2018-2029)
1.6.5 Middle East & Africa Automation in Biopharmaceutical Market Size (2018-2029)
2 Automation in Biopharmaceutical Market by Type
2.1 Introduction
2.1.1 Clinical Stage Automation
2.1.2 Drug Discovery Stage Automation
2.2 Global Automation in Biopharmaceutical Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Automation in Biopharmaceutical Historic Market Size by Type (2018-2023)
2.2.2 Global Automation in Biopharmaceutical Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Automation in Biopharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Automation in Biopharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Automation in Biopharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Automation in Biopharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Automation in Biopharmaceutical Revenue Breakdown by Type (2018-2029)
3 Automation in Biopharmaceutical Market Overview by Application
3.1 Introduction
3.1.1 Research and Development
3.1.2 Clinical
3.2 Global Automation in Biopharmaceutical Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Automation in Biopharmaceutical Historic Market Size by Application (2018-2023)
3.2.2 Global Automation in Biopharmaceutical Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Automation in Biopharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Automation in Biopharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Automation in Biopharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Automation in Biopharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Automation in Biopharmaceutical Revenue Breakdown by Application (2018-2029)
4 Automation in Biopharmaceutical Competition Analysis by Players
4.1 Global Automation in Biopharmaceutical Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Automation in Biopharmaceutical as of 2022)
4.3 Date of Key Players Enter into Automation in Biopharmaceutical Market
4.4 Global Top Players Automation in Biopharmaceutical Headquarters and Area Served
4.5 Key Players Automation in Biopharmaceutical Product Solution and Service
4.6 Competitive Status
4.6.1 Automation in Biopharmaceutical Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Danaher
5.1.1 Danaher Profile
5.1.2 Danaher Main Business
5.1.3 Danaher Automation in Biopharmaceutical Products, Services and Solutions
5.1.4 Danaher Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.1.5 Danaher Recent Developments
5.2 GE
5.2.1 GE Profile
5.2.2 GE Main Business
5.2.3 GE Automation in Biopharmaceutical Products, Services and Solutions
5.2.4 GE Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.2.5 GE Recent Developments
5.3 PerkinElmer
5.3.1 PerkinElmer Profile
5.3.2 PerkinElmer Main Business
5.3.3 PerkinElmer Automation in Biopharmaceutical Products, Services and Solutions
5.3.4 PerkinElmer Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.3.5 Tecan Trading Recent Developments
5.4 Tecan Trading
5.4.1 Tecan Trading Profile
5.4.2 Tecan Trading Main Business
5.4.3 Tecan Trading Automation in Biopharmaceutical Products, Services and Solutions
5.4.4 Tecan Trading Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.4.5 Tecan Trading Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Bruker
5.6.1 Bruker Profile
5.6.2 Bruker Main Business
5.6.3 Bruker Automation in Biopharmaceutical Products, Services and Solutions
5.6.4 Bruker Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.6.5 Bruker Recent Developments
5.7 Peak Analysis and Automation
5.7.1 Peak Analysis and Automation Profile
5.7.2 Peak Analysis and Automation Main Business
5.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Products, Services and Solutions
5.7.4 Peak Analysis and Automation Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.7.5 Peak Analysis and Automation Recent Developments
5.8 Waters
5.8.1 Waters Profile
5.8.2 Waters Main Business
5.8.3 Waters Automation in Biopharmaceutical Products, Services and Solutions
5.8.4 Waters Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.8.5 Waters Recent Developments
5.9 Capsugel
5.9.1 Capsugel Profile
5.9.2 Capsugel Main Business
5.9.3 Capsugel Automation in Biopharmaceutical Products, Services and Solutions
5.9.4 Capsugel Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.9.5 Capsugel Recent Developments
5.10 RheoSense
5.10.1 RheoSense Profile
5.10.2 RheoSense Main Business
5.10.3 RheoSense Automation in Biopharmaceutical Products, Services and Solutions
5.10.4 RheoSense Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.10.5 RheoSense Recent Developments
5.11 Eirechrom
5.11.1 Eirechrom Profile
5.11.2 Eirechrom Main Business
5.11.3 Eirechrom Automation in Biopharmaceutical Products, Services and Solutions
5.11.4 Eirechrom Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.11.5 Eirechrom Recent Developments
5.12 BioProcess International
5.12.1 BioProcess International Profile
5.12.2 BioProcess International Main Business
5.12.3 BioProcess International Automation in Biopharmaceutical Products, Services and Solutions
5.12.4 BioProcess International Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.12.5 BioProcess International Recent Developments
5.13 Novasep
5.13.1 Novasep Profile
5.13.2 Novasep Main Business
5.13.3 Novasep Automation in Biopharmaceutical Products, Services and Solutions
5.13.4 Novasep Automation in Biopharmaceutical Revenue (US$ Million) & (2018-2023)
5.13.5 Novasep Recent Developments
6 North America
6.1 North America Automation in Biopharmaceutical Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Automation in Biopharmaceutical Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Automation in Biopharmaceutical Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Automation in Biopharmaceutical Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Automation in Biopharmaceutical Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Automation in Biopharmaceutical Market Dynamics
11.1 Automation in Biopharmaceutical Industry Trends
11.2 Automation in Biopharmaceutical Market Drivers
11.3 Automation in Biopharmaceutical Market Challenges
11.4 Automation in Biopharmaceutical Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
